ClinicalTrials.gov
public full text
Public Domain
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
To explore the efficacy and pharmacodynamic effects of omiganan topical gel in facial seborrheic dermatitis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis#1137892
- Dupixent and Narrowband UVB for Atopic Dermatitis#828156
- Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome#968556
- Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT#854377
- Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients#1138154
Record · ID 1031012
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive